<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00993538</url>
  </required_header>
  <id_info>
    <org_study_id>4452</org_study_id>
    <nct_id>NCT00993538</nct_id>
  </id_info>
  <brief_title>Leukemia Cell Cultures for Research of New Anti-Cancer Therapies</brief_title>
  <official_title>Leukemia Cell Cultures for Research of New Anti-cancer Therapies</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this project is not only a better understanding of the human leukemic
      disease but also to find new anti-leukemic or improve existing ones. This study has, the
      following aims:

        -  To analyze the genetic and epigenetic regulation of the retinoic acid induced cascade
           which leads to the expression of TRAIL in blood cells of patients with acute leukemia.
           This study will be complemented by the analysis of global gene expression (DNA chips)
           and of the DNA methylation state, and by chromatin immunoprecipitation experiences.

        -  To determine the efficiency of inhibitors of enzymes responsible for the modification of
           chromatin (existing and new developments within the European consortium EPITRON
           coordinated by Dr Gronemeyer) as inducers of differentiation and / or apoptosis of
           leukemic blasts.

        -  To explore Ikaros genic and functional abnormalities (genomic deletions, mutations,
           abnormal transcripts and proteins) in acute leukemia. The aim is to determine if these
           abnormalities may play a prognosis role.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Acute Leukaemia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood sampling</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Bone marrow aspiration</intervention_name>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with suspected de novo or secondary or relapsed acute leukemia, requiring
             complementary blood test and bone marrow analysis

          -  Patients older or equal than 28 days

          -  Informed consent signed

        Exclusion Criteria:

          -  Pregnancy

          -  Breastfeeding
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raoul Herbrecht, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Département d'Hématologie et d'Oncologie-hôpital de Hautepierre Strasbourg, France</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raoul Herbrecht, MD</last_name>
    <phone>3.33.88.12.83.79</phone>
    <email>Raoul.herbrecht@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Patrick lutz, MD</last_name>
    <phone>3.33.88.12.80.90</phone>
    <email>Patrick.lutz@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Service d'Hématologie et d'Oncologie</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raoul Herbrecht, MD</last_name>
      <phone>3.33.88.12.83.79</phone>
      <email>Raoul.herbrecht@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Raoul Herbrecht, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cécile Fohrer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luc Fornecker, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bruno Lioure, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karin Bilger, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Pédiaterie - Hôpital de Hautepierre</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick Lutz, MD</last_name>
      <phone>3.33.88.12.80.90</phone>
      <email>Patrick.lutz@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Patrick Lutz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Natacha Entz-Werle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>August 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2009</study_first_submitted>
  <study_first_submitted_qc>October 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2009</study_first_posted>
  <last_update_submitted>August 29, 2011</last_update_submitted>
  <last_update_submitted_qc>August 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 30, 2011</last_update_posted>
  <responsible_party>
    <name_title>Christine GEILLER/Directeur de la Recherche Clinique et des Innovations</name_title>
    <organization>University Hospital, Strasbourg, France</organization>
  </responsible_party>
  <keyword>Leukaemia</keyword>
  <keyword>Blood and marrow cells culture</keyword>
  <keyword>Cell growth</keyword>
  <keyword>Cell differentiation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Leukemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

